232 related articles for article (PubMed ID: 18430833)
21. Application of sonographic BI-RADS to synchronous breast nodules detected in patients with breast cancer.
Kim SJ; Ko EY; Shin JH; Kang SS; Mun SH; Han BK; Cho EY
AJR Am J Roentgenol; 2008 Sep; 191(3):653-8. PubMed ID: 18716090
[TBL] [Abstract][Full Text] [Related]
22. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography.
Taskin F; Koseoglu K; Ozbas S; Erkus M; Karaman C
J Clin Ultrasound; 2012 Jun; 40(5):261-5. PubMed ID: 22508447
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.
Dobrosavljević A; Rakić S; Nikoli B; Raznatović SJ; Dikić SD; Milosević Z; Jurisić A; Skrobić M
Vojnosanit Pregl; 2016 Mar; 73(3):239-45. PubMed ID: 27295907
[TBL] [Abstract][Full Text] [Related]
24. Does power Doppler ultrasonography improve the BI-RADS category assessment and diagnostic accuracy of solid breast lesions?
Tozaki M; Fukuma E
Acta Radiol; 2011 Sep; 52(7):706-10. PubMed ID: 21596798
[TBL] [Abstract][Full Text] [Related]
25. Value of the US BI-RADS final assessment following mastectomy: BI-RADS 4 and 5 lesions.
Gweon HM; Son EJ; Youk JH; Kim JA; Chung J
Acta Radiol; 2012 Apr; 53(3):255-60. PubMed ID: 22302210
[TBL] [Abstract][Full Text] [Related]
26. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.
Bent CK; Bassett LW; D'Orsi CJ; Sayre JW
AJR Am J Roentgenol; 2010 May; 194(5):1378-83. PubMed ID: 20410428
[TBL] [Abstract][Full Text] [Related]
27. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
Wiratkapun C; Lertsithichai P; Wibulpholprasert B
J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
29. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
Satake H; Nishio A; Ikeda M; Ishigaki S; Shimamoto K; Hirano M; Naganawa S
AJR Am J Roentgenol; 2011 Jan; 196(1):202-9. PubMed ID: 21178068
[TBL] [Abstract][Full Text] [Related]
30. Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions.
Wiratkapun C; Bunyapaiboonsri W; Wibulpolprasert B; Lertsithichai P
J Med Assoc Thai; 2010 Jul; 93(7):830-7. PubMed ID: 20649064
[TBL] [Abstract][Full Text] [Related]
31. Solid breast mass characterisation: use of the sonographic BI-RADS classification.
Costantini M; Belli P; Ierardi C; Franceschini G; La Torre G; Bonomo L
Radiol Med; 2007 Sep; 112(6):877-94. PubMed ID: 17885742
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of BI-RADS classification for breast imaging in women under age 50.
Kennedy G; Markert M; Alexander JR; Avisar E
Breast Cancer Res Treat; 2011 Dec; 130(3):819-23. PubMed ID: 21748292
[TBL] [Abstract][Full Text] [Related]
33. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
[TBL] [Abstract][Full Text] [Related]
34. Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time.
Raghu M; Durand MA; Andrejeva L; Goehler A; Michalski MH; Geisel JL; Hooley RJ; Horvath LJ; Butler R; Forman HP; Philpotts LE
Radiology; 2016 Oct; 281(1):54-61. PubMed ID: 27139264
[TBL] [Abstract][Full Text] [Related]
35. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital.
Noonpradej S; Wangkulangkul P; Woodtichartpreecha P; Laohawiriyakamol S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):531-536. PubMed ID: 33639670
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the results after using of the BI-RADS categories in 1,777 clinical mammograms].
Hauth EA; Khan K; Wolfgarten B; Betzler A; Kimmig R; Forsting M
Radiologe; 2008 Mar; 48(3):281-8. PubMed ID: 17265008
[TBL] [Abstract][Full Text] [Related]
37. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
39. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
[TBL] [Abstract][Full Text] [Related]
40. Subcategorization of ultrasonographic BI-RADS category 4: positive predictive value and clinical factors affecting it.
Yoon JH; Kim MJ; Moon HJ; Kwak JY; Kim EK
Ultrasound Med Biol; 2011 May; 37(5):693-9. PubMed ID: 21458145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
